Showing 1,516 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

HIV Drug Prices Keep Rising. Why Is No One Talking About It?

Editor's pick
The Body
30 January 2019
Pharmaceutical industry

The Economics Of Cures - Gilead At A Turning Point

Editor's pick
Seeking Alpha
28 January 2019
Elimination of hepatitis C

UK court dismisses AbbVie's legal challenge against the NHS

Editor's pick
The Lancet (free registration required)
25 January 2019
Elimination of hepatitis C

NHS England’s plan to eliminate Hepatitis C decisively backed by High Court

Editor's pick
NHS England
18 January 2019
Low CD4 count

‘Left behind’: Drug companies and researchers have overlooked patients who don’t respond to HIV meds

Editor's pick
STAT
8 January 2019
Pharmaceutical industry

Merck loses bid to revive $200 million Gilead verdict at U.S. high court

Editor's pick
Reuters UK
8 January 2019
Generic medicines

Cipla recalls 4,800 bottles of anti-HIV tablets from American market

Editor's pick
Business Today
30 December 2018
Access to healthcare

UK-CAB statement on Brexit, HIV and access to medicines

Editor's pick
UK-CAB
20 December 2018
Finance & funding

So Close, Yet So Far: Why is HIV/AIDS Funding Decreasing?

Editor's pick
Inside Philanthropy
19 December 2018
Pharmaceutical industry

Biktarvy's success raises doubts about ViiV's 'new era' of HIV treatment

Editor's pick
BioPharma Dive
12 December 2018
Access to healthcare

Bringing Down the House on Intellectual Property and Access

Editor's pick
Treatment Action Group
10 December 2018
Pharmaceutical industry

Roche Executive Daniel O’Day Is Named Gilead CEO

Editor's pick
Wall Street Journal
10 December 2018
HIV treatment for children & young people

Pharmaceutical corporations are failing children with HIV

Editor's pick
Médecins Sans Frontières (MSF)
30 November 2018
Access to healthcare

Trump Wants to Restrict Access to HIV Meds for People on Medicare

Editor's pick
Poz
29 November 2018
HIV treatment for children & young people

MSF: Pharmaceutical corporations failing children with HIV

Editor's pick
Doctors Without Borders
29 November 2018
Generic medicines

Gilead investors spooked by UnitedHealthcare push to cut HIV drug costs

Editor's pick
FiercePharma
5 November 2018
Pharmaceutical industry

Gilead's HIV portfolio soars, but is it enough to combat falling HCV sales?

Editor's pick
FiercePharma
29 October 2018
Pharmaceutical industry

Patients 'may need to stockpile own drugs if no-deal Brexit looms'

Editor's pick
The Guardian
23 October 2018
Drug-resistant TB

Johnson & Johnson prices keep key TB medicines out of reach

Editor's pick
MSF
23 October 2018
The search for a cure

Gilead and Aelix join forces to pursue HIV 'cure'

Editor's pick
PMLiVE
18 October 2018
Access to healthcare

The health innovation system is ‘broken’ and failing patients

Editor's pick
STOP AIDS
18 October 2018
Access to healthcare

Impatient patients turn to online 'buyers club' for new drugs

Editor's pick
Reuters
3 October 2018
Pharmaceutical industry

Fears over HIV drugs in event of ‘no deal’ Brexit

Editor's pick
Gay Star News
2 October 2018
Pharmaceutical industry

What It Means for Gilead to Launch Its Own Generics for Hepatitis C Treatments

Editor's pick
24/7 Wall St.
25 September 2018